Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
SAN FRANCISCO — Sanofi CEO Paul Hudson reiterated his ambitions for the “new” Sanofi, including business development plans ahead of what some experts predict will
Success with “treat-to-target” therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of
Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas (APAs)-adrenal gland tumors that drive high blood pressure.
Telehealth claims data suggest service duplication, Roche app to evaluate MS symptom
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
Paul Hudson is ‘open-minded’ to M&A as he plots Sanofi’s transformation: #JPM24
SAN FRANCISCO — Sanofi CEO Paul Hudson reiterated his ambitions for the “new” Sanofi, including business development plans ahead of what some experts predict will
Study: Treat-to-Target Success in Early RA Is Durable
Success with “treat-to-target” therapy for early-stage rheumatoid arthritis (RA) lasted up to 20 years, according to researchers who followed up with participants in two of
Researchers uncover a surprising layer of complexity in aldosterone-producing tumors
Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas (APAs)-adrenal gland tumors that drive high blood pressure.